STUTTGART, Germany I August 14, 2025 I Selecting the right target remains the most important decision to make in drug discovery and has to be seen in light of drug modality technologies available for a R&D organization. La Merie Publishing has released a new service offering which evaluates customer-selected targets for drug discovery in the biopharmaceutical industry in three predefined packages (basic, standard and premium) with clear pricing, timelines, and deliverables, allowing clients to purchase services with minimal project management overhead.
Target Evaluation for Drug Discovery:
Pre-Scoped Standard Evaluation
This pre-defined nature makes it easy for clients to purchase services quickly, without the need for extensive communication or negotiation. The standardized services can be amended by client specific needs and mutual agreement.
The evaluation of customer-selected targets for drug discovery is conducted by La Merie’s experts with long-standing experience in research and development of biological product candidates in the pharmaceutical and biotechnolgoy industry. La Merie Publishing has a proven track record in publishing reports about competitor analysis, target evaluation, drug profiling, technology assessment and analyzing terms of partnering deals (see recent reports at https://lamerie.com/reports/ ).
These services can be ordered at La Merie Publishing’s online store:
https://lamerie.com/report/target-evaluation-for-drug-discovery-pre-scoped-basic-evaluation/
https://lamerie.com/report/target-evaluation-for-drug-discovery-pre-scoped-standard-evaluation/
https://lamerie.com/report/target-evaluation-for-drug-discovery-pre-scoped-premium-evaluation/
About La Merie Publishing
La Merie Publishing is an independent business information provider for the biotechnology and pharmaceutical industry. La Merie Publishing prepares brief and full reports. La Merie Publishing products can be purchased in the online store www.lamerie.com and from selected Resellers.
La Merie Publishing offers the service of custom report preparation for corporate clients, including, but not limited to, customized reports about target evaluation, pipeline analysis, technology assessments, drug and competitor profiles, partnering and business deal terms and any other competitive intelligence elaboration of interest.
SOURCE: La Merie Publishing